Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Narayana Hrudayalaya's Equity-to-Asset or its related term are showing as below:
NSE:NH'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.36 Med: 0.48 Max: 0.59
Current: 0.36
During the past 13 years, the highest Equity to Asset Ratio of Narayana Hrudayalaya was 0.59. The lowest was 0.36. And the median was 0.48.
NSE:NH's Equity-to-Asset is ranked worse than 64.77% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 0.49
vs NSE:NH: 0.36
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Narayana Hrudayalaya Equity-to-Asset Related Terms
Narayana Hrudayalaya Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Narayana Hrudayalaya's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NH vs HCA, THC, EHC: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Narayana Hrudayalaya's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Narayana Hrudayalaya Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Narayana Hrudayalaya's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Narayana Hrudayalaya's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Narayana Hrudayalaya's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Narayana Hrudayalaya (NSE:NH) has a Equity-to-Asset of 0.00 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Narayana Hrudayalaya and its competitors. Over the past decade, Narayana Hrudayalaya's Equity-to-Asset has ranged from 0.36 to 0.59. According to the industry distribution chart, Narayana Hrudayalaya ranks #443 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 64.8%.
Is Narayana Hrudayalaya's Equity-to-Asset too high?
Narayana Hrudayalaya's current Equity-to-Asset is 0.00. Over the past 10 years, this metric has ranged from a low of 0.36 to a high of 0.59. Based on the distribution chart, Narayana Hrudayalaya ranks #443 out of 684 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Narayana Hrudayalaya has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Narayana Hrudayalaya's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Narayana Hrudayalaya ranks #443 out of 684 companies for Equity-to-Asset. This places Narayana Hrudayalaya in the lower half of its industry. The industry median Equity-to-Asset is 0.49. Historically, Narayana Hrudayalaya's own Equity-to-Asset has ranged from 0.36 to 0.59 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Narayana Hrudayalaya and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Narayana Hrudayalaya's current Equity-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Narayana Hrudayalaya stock overvalued right now?
Based on GuruFocus' analysis, Narayana Hrudayalaya (NSE:NH) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,487.07, compared to a current price of ₹1,869.20 — trading 24.8% below its estimated fair value. The current Equity-to-Asset is 0.00. Narayana Hrudayalaya's overall GF Score™ is 96/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Narayana Hrudayalaya (NSE:NH), the current Equity-to-Asset is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Narayana Hrudayalaya (NSE:NH) Overvalued in 2026?
Based on GuruFocus' analysis, Narayana Hrudayalaya stock appears to be undervalued.
The current stock price of ₹1,869.20 is trading 24.8% below its estimated GF Value™ of ₹2,487.07.
GuruFocus considers Narayana Hrudayalaya to be Modestly Undervalued.
Key valuation signals for NSE:NH:
Equity-to-Asset: 0.00
GF Value™: ₹2,487.07 vs. price of ₹1,869.20 (24.8% below fair value)
No single metric tells the full story. See the NSE:NH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Narayana Hrudayalaya Ltd is an India-based medical and healthcare service provider. The company is engaged in the business of running and operating hospitals, clinics, health centers, nursing homes, and other related activities. The Company's sole operating segment is Medical and Healthcare Related Services. It also provides surgery services such as Cardiac Surgery, nephrology, urology, neurology, neurosurgery, endocrinology, orthopaedics, internal medicine, obstetrics, gynaecology, paediatrics, neonatology, gastroenterology, and oncology. It has business operations in India and the Rest of the world, of which the maximum revenue is generated from the business operations in India.
96GF Score
Get the complete analysis for NSE:NH
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NH has been successfully added to your 
